Ionis Pharmaceuticals Historical PE Ratio image   This IONS PE ratio history page last updated 3/11/2024
Ionis Pharmaceuticals Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q4 2023
2/21/2024
43.53-0.06-0.24NA
Q3 2023
11/2/2023
43.73-0.85-3.40NA
Q2 2023
8/9/2023
39.99-0.41-1.64NA
Q1 2023
5/3/2023
34.73-0.68-2.72NA
Q4 2022
2/22/2023
36.80-1.18-4.72NA
Q3 2022
11/9/2022
43.06-0.16-0.64NA
Q2 2022
8/9/2022
44.26-0.56-2.24NA
Q1 2022
5/4/2022
39.58-0.27-1.08NA
Q4 2021
2/24/2022
32.491.556.205.2
Q3 2021
11/3/2021
33.76-0.34-1.36NA
Q2 2021
8/4/2021
37.81-0.26-1.04NA
Q1 2021
5/5/2021
39.89-0.32-1.28NA
Q4 2020
2/24/2021
56.210.813.2417.3
Q3 2020
11/4/2020
47.61-0.22-0.88NA
Q2 2020
8/5/2020
57.48-0.23-0.92NA
Q1 2020
5/6/2020
56.51-0.35-1.40NA
Q4 2019
2/26/2020
56.021.335.3210.5
Q3 2019
11/6/2019
55.600.180.7277.2
Q2 2019
8/7/2019
67.68-0.01-0.04NA
Q1 2019
5/9/2019
67.360.622.4827.2
Q4 2018
2/27/2019
70.940.190.7693.3
Q3 2018
11/6/2018
53.65-0.03-0.12NA
Q2 2018
8/7/2018
44.20-0.05-0.20NA
Q1 2018
5/4/2018
44.01-0.01-0.04NA
Q4 2017
2/27/2018
51.470.200.8064.3
Q3 2017
11/7/2017
52.300.130.52100.6
Q2 2017
8/8/2017
48.31-0.09-0.36NA
Q1 2017
5/9/2017
46.800.200.8058.5
Q4 2016
2/28/2017
49.770.240.9651.8
Q3 2016
11/9/2016
38.380.060.24159.9
Q2 2016
8/9/2016
36.33-0.47-1.88NA
Q1 2016
5/4/2016
35.25-0.36-1.44NA
Q4 2015
2/25/2016
33.57-0.45-1.80NA
Q3 2015
11/9/2015
62.77-0.17-0.68NA
Q2 2015
8/4/2015
55.300.291.1647.7
Q1 2015
5/5/2015
58.34-0.14-0.56NA
Q4 2014
2/27/2015
68.560.321.2853.6
Q3 2014
11/7/2014
44.59-0.23-0.92NA
Q2 2014
8/4/2014
31.42-0.10-0.40NA
Q1 2014
5/6/2014
24.66-0.27-1.08NA
Q4 2013
2/28/2014
51.00-0.21-0.84NA
Q3 2013
11/5/2013
32.55-0.21-0.84NA
Q2 2013
8/6/2013
27.75-0.09-0.36NA
Q1 2013
5/7/2013
21.89-0.02-0.08NA
Q4 2012
2/28/2013
14.70-0.03-0.12NA
Q3 2012
11/6/2012
8.09-0.37-1.48NA
Q2 2012
8/6/2012
13.19-0.01-0.04NA
Q1 2012
5/8/2012
8.32-0.24-0.96NA
Ionis Pharmaceuticals PE History Chart
PeriodPriceGAAPTTMPE
Q4 2023
2/21/2024
43.53-0.06-2.00NA
Q3 2023
11/2/2023
43.73-0.85-3.12NA
Q2 2023
8/9/2023
39.99-0.41-2.43NA
Q1 2023
5/3/2023
34.73-0.68-2.58NA
Q4 2022
2/22/2023
36.80-1.18-2.17NA
Q3 2022
11/9/2022
43.06-0.160.5676.9
Q2 2022
8/9/2022
44.26-0.560.38116.5
Q1 2022
5/4/2022
39.58-0.270.6858.2
Q4 2021
2/24/2022
32.491.550.6351.6
Q3 2021
11/3/2021
33.76-0.34-0.11NA
Q2 2021
8/4/2021
37.81-0.260.01>500
Q1 2021
5/5/2021
39.89-0.320.04>500
Q4 2020
2/24/2021
56.210.810.01>500
Q3 2020
11/4/2020
47.61-0.220.5389.8
Q2 2020
8/5/2020
57.48-0.230.9361.8
Q1 2020
5/6/2020
56.51-0.351.1549.1
Q4 2019
2/26/2020
56.021.332.1226.4
Q3 2019
11/6/2019
55.600.180.9856.7
Q2 2019
8/7/2019
67.68-0.010.7787.9
Q1 2019
5/9/2019
67.360.620.7392.3
Q4 2018
2/27/2019
70.940.190.10>500
Q3 2018
11/6/2018
53.65-0.030.11487.7
Q2 2018
8/7/2018
44.20-0.050.27163.7
Q1 2018
5/4/2018
44.01-0.010.23191.3
Q4 2017
2/27/2018
51.470.200.44117.0
Q3 2017
11/7/2017
52.300.130.48109.0
Q2 2017
8/8/2017
48.31-0.090.41117.8
Q1 2017
5/9/2017
46.800.200.03>500
Q4 2016
2/28/2017
49.770.24-0.53NA
Q3 2016
11/9/2016
38.380.06-1.22NA
Q2 2016
8/9/2016
36.33-0.47-1.45NA
Q1 2016
5/4/2016
35.25-0.36-0.69NA
Q4 2015
2/25/2016
33.57-0.45-0.47NA
Q3 2015
11/9/2015
62.77-0.170.30209.2
Q2 2015
8/4/2015
55.300.290.24230.4
Q1 2015
5/5/2015
58.34-0.14-0.15NA
Q4 2014
2/27/2015
68.560.32-0.28NA
Q3 2014
11/7/2014
44.59-0.23-0.81NA
Q2 2014
8/4/2014
31.42-0.10-0.79NA
Q1 2014
5/6/2014
24.66-0.27-0.78NA
Q4 2013
2/28/2014
51.00-0.21-0.53NA
Q3 2013
11/5/2013
32.55-0.21-0.35NA
Q2 2013
8/6/2013
27.75-0.09-0.51NA
Q1 2013
5/7/2013
21.89-0.02-0.43NA
Q4 2012
2/28/2013
14.70-0.03-0.65NA
Q3 2012
11/6/2012
8.09-0.37NANA
Q2 2012
8/6/2012
13.19-0.01NANA
Q1 2012
5/8/2012
8.32-0.24NANA
Quotes delayed 20 minutes

Email EnvelopeFree IONS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Ionis Pharmaceuticals (IONS) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

IOVA PE Ratio History
IPSC PE Ratio History
IQV PE Ratio History
IRIX PE Ratio History
IRMD PE Ratio History
IRTC PE Ratio History
IRWD PE Ratio History
ISEE PE Ratio History
ISO PE Ratio History
ISPC PE Ratio History
How should the IONS historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Ionis Pharmaceuticals. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this IONS Historical PE Ratio page.

What is the average historical PE for IONS based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The IONS historical PE ratio using the annualized quarterly earnings method works out to 59.0.

What is the average historical PE for IONS based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The IONS historical PE ratio using the TTM earnings method works out to 126.0.

On this page we presented the Ionis Pharmaceuticals Historical PE Ratio information for Ionis Pharmaceuticals' stock. The average IONS historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 59.0. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average IONS historical PE based on this TTM earnings result method is 126.0. Note: any PE calculations resulting in a value exceeding 500 were discarded as not meaningful. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this IONS historical PE result, against the recent PE: when this page was posted on 3/8/2024, the most recent closing price for IONS had been 43.99, and the most recent quarterly earnings result, annualized, was 6.2. Meanwhile, the most recent TTM earnings summed to 0.56. From these numbers, we calculate the recent IONS PE on 3/8/2024 based on annualized quarterly EPS was 7.1. Based on IONS's history, that recent PE is low relative to the historical average, with the recent PE 88.0% lower than the historical average PE across our data set for Ionis Pharmaceuticals. Looking at the recent IONS PE on 3/8/2024 based on TTM EPS, we calculate the ratio at 78.6. Based on IONS's history, that recent PE is low relative to the historical average, with the recent PE 37.6% lower than the average PE across our Ionis Pharmaceuticals data set with TTM EPS used in the calculation at each period.

For self directed investors doing their due diligence on IONS or any other given stock, valuation analysis for IONS can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Ionis Pharmaceuticals PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for IONS. Thanks for visiting, and the next time you need to research IONS Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: ILCB Videos, IRDM Insider Buying, SCVX YTD Return.

 

Ionis Pharmaceuticals Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.